Georgia CTSA Newsletter

Trouble viewing this email? Click here to view on the web.


Georgia CTSA
Weekly eRoundup

May 25, 2018

In this edition:


Feature
Funding
Education
Research Resources
Innovation & Translation
Community
Events
News
 
 

Feature

 
 
 
Feature Image

UGA College of Veterinary Medicine accepted as member of the Clinical and Translational Science Award One Health Alliance

The University of Georgia College of Veterinary Medicine has been accepted as a member of the Clinical and Translational Science Award One Health Alliance (COHA). UGA joined a Clinical and Translational Science Award (CTSA) in September (read the news release), along with Emory University, Morehouse School of Medicine, and the Georgia Institute of Technology, the four academic partner institutions makeup the Georgia Clinical & Translational ...

 
Read More
 
 
 
 
 

Georgia CTSA Grady Clinical Research Unit Director, Umpierrez wins Lifetime Achievement Award

Read More
 
 
 

Funding

 
 
 

Medtronic Foundation New Grant Opportunity-Due June 14

The foundation is seeking project applications to improve health-care access and outcomes for underserved populations, particularly addressing chronic conditions and noncommunicable diseases. Health organizations and other related groups may apply for one-year grants worth $50,000 to $100,000; up to 10 grants will be awarded.
 
Read More
 
 
 
 

Racial & Ethnic Approaches to Community Health (REACH)-Due July 16

This fine-year initiative is to improve health, prevent chronic diseases, and reduce health disparities among racial and ethnic populations with the highest risk, or burden, of chronic disease, specifically for African Americans, Hispanic Americans, Asian Americans, Native Hawaiian/Other Pacific Islanders, American Indians, and Alaska Natives.
 
Read More
 
 
 
 

NIH Support for Conferences & Scientific Meetings (Parent R13)

The purpose of the grant is to support high quality conferences that are relevant to the public health and to the scientific mission of the participating Institutes and Centers.
 
Read More
 
 
 
 

2019 NIH Director's New Innovator Award (DP2-Clinical Trial Optional)-Due September 10

Supports exceptionally creative early career scientists proposing innovative and high-impact projects. The NIH definition of an Early Stage Investigator now includes clinical training. RFA-RM-18-008
 
Read More
 
 
 
 

Collaborative network to advance deprescribng research for older adults with multiple chronic conditions (R24 clinical trial optional)-LOI Due September 18

Deprescribing, the cessation of long-term therapy under clinician supervision, is a fundamental technique of geriatric practice and palliative medicine to address inappropriate medication use and/or polypharmacy common among older adults with multimorbidity.
 
Read More
 
 
 
 

2019 NIH Director's Transformative Research Award (R01-Clinical Trial Optional)-Due September 21

Supports individuals or teams proposing projects that are inherently risky and untested but have the potential to create or overturn fundamental paradigms.
 
Read More
 
 
 

Education

 
 
 

Stimulating Access to Research in Residency (StARR)-Due September 24

The purpose of this program is to recruit and retain outstanding, postdoctoral-level health professionals who have demonstrated potential and interest in pursuing careers as clinician-investigators.
 
Read More
 
 
 
 

American Heart Association Career Development Award-Due October 17

This FOA supports highly promising healthcare and academic professionals, in the early years of one's first professional appointment, to explore innovative questions or pilot studies that will provide preliminary data and training necessary to assure the applicant's future success as a research scientist in the field of cardiovascular and stroke research.
 
Read More
 
 
 

Research Resources

 
 
 

Georgia CTSA Ethical Dilemma of the Week

Authorship-Read this, but don't tell anybody
 
Read More
 
 
 
 

Podcast & Video Series-Patient-Reported Outcomes: Design with the End in Mind

FasterCures continues the important work of evaluating how the biomedical research and development system measures and utilizes the outcomes that matter most to patients.
 
Read More
 
 
 

Innovation & Translation

 
 
 

NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 - Clinical Trial Optional)-Due July 27

The purpose of the award is to facilitate and accelerate the capital-intensive steps that are required to transition SBIR/STTR Phase II projects to the commercialization stage by promoting partnerships between SBIR/STTR Phase II awardees and third-party investors and/or strategic partners. Applicants must submit a Commercialization Plan, which should include details on any independent third-party funding that has already been secured or is anticipated during the Phase IIB Bridge Award project period.
 
Read More
 
 
 
 

NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)-Due July 27

The purpose of the award is to provide support to Phase II SBIR or STTR awardees that are developing NHLBI mission-related products that address a rare disease or young pediatric populations. The goal of this FOA is for these products to be further validated so that development can continue with private funding after NHLBI support ends. Applicants must submit a Commercialization Plan that includes details on any independent third-party funding that has already been secured or is anticipated during the project period.
 
Read More
 
 
 

Community

 
 
 

NIH Minority Health & Health Disparities Community Listening Session-Wednesday

This session is an opportunity for community members to provide meaningful input on the NIH-wide Minority Health and Health Disparities Strategic Plan. Held at Morehouse School of Medicine from 8:30 a.m.-12:30 p.m. Provide input on the national agenda and priorities for minority health and health disparities research, strategic partnerships, initiatives, and dissemination. Opening remarks by Dr. Eliseo J. Perez-Stable, director of the National Institute on Minority Health and Health Disparities.
 
Read More
 
 
 
 

Emory & Morehouse School of Medicine joins NIH in launching All of Us Research Program to advance precision medicine

 
Read More
 
 
 
 

8th Annual Winship Win the Fight 5K-October 13

The 5K is a family friendly event that will raise money for innovative cancer research at Winship Cancer Institute of Emory University, starting at 8:30 a.m. on Emory's Quad.
 
Read More
 
 
 

Events

 
 
 

Take Your Biotech Idea From Lab to Market-Wednesday

NCATS will jointly host a webinar about NIH's small business funding and applicant support programs. Sponsored in part by NCATS, the National Cancer Institute's (NCI) Small Business Innovation Research (SBIR) Development Center and the Women's Business Development Center (WBDC), the webinar will focus on NIH's SBIR and Small Business Technology Transfer funding programs, NCI and NCATS resources, and free applicant assistance programs.
 
Read More
 
 
 
 

UGA I-Corps Final Pitches-Thursday

Hear final pitches from thirteen creative UGA I-Corps Accelerator teams participating in the May 2018 cohort. These teams demonstrate the spectrum of UGA innovation and the people who drive it forward. Stop by from 4:00-6:00 p.m. for some refreshments and great ideas!
 
Read More
 
 
 
 

Introducing Figshare, a Free Repository where Researchers Can Make all of Their Research Outputs Available in a Citable, Shareable & Discoverable Manner-June 6

This webinar will introduce Figshare, a free, online digital repository where researchers can preserve and share their research outputs, including figures, datasets, images, and videos.
 
Read More
 
 
 
 

FDA's Patient-focused Drug Development Initiative-June 7

FasterCures will host a webinar to discuss the FDA's Patient-Focused Drug Development (PFDD) initiative. During this webinar, panelists will share their experiences working with patient communities to plan for these often-intense PFDD listening sessions, as well as what they've learned from them and how they are applying this information.
 
Read More
 
 
 
 

Trial Innovation Network Toolkit Overview-July 18

This webinar will include an overview of the resources available on the Trial Innovation Network Toolkit. From study design to participant recruitment and engagement, the Trial Innovation Network offers many self-service tools and resources to help investigators throughout the entire life cycle of their projects.
 
Read More
 
 
 
 
Feature Image

Call for Abstracts: 2nd Annual Georgia Clinical & Translational Science Conference-Due December 3

Clinical and/or translational researchers working in the state of Georgia are invited to submit an abstract. Michael G Kurilla, MD, PhD, director, Division of Clinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health will serve as keynote speaker. Georgia CTSA brings together researchers from across the state to present the best new clinical and translational research and build collaborative ...

 
Read More
 
 
 

News

 
 
 

NCATS Seeks Stem Cell Research Collaborators

NCATS seeks scientific investigators from the NIH intramural and extramural communities, as well as those from the biotech and pharmaceutical industry, to collaborate on projects through its Stem Cell Translation Laboratory (SCTL). The next proposal deadline is July 1, 2018. The SCTL is a state-of-the-art research facility designed to address the scientific and technological challenges in the induced pluripotent stem cell (iPSC) field.
 
Read More
 
 

For more information on Georgia Clinical & Translational Science Alliance (Georgia CTSA), please visit www.GeorgiaCTSA.org. Do you have news, seminars, or events of interest to clinical and translational researchers? Send them to GeorgiaCTSA@emory.edu by noon on Thursday. To suggest subscribers or unsubscribe to the listserv please email GeorgiaCTSA@emory.edu.

Please include the following citation in any publications resulting from direct or indirect Georgia CTSA support, "Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR002378. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health." KL2 Scholars should also list KL2TR002381 and TL1 Trainees should also list TL1TR002382.